Most recent articles by:

Editorial Team

- Advertisement -

Morphic’s EMERALD-1 trial for ulcerative colitis disappoints

Investors have raised a concern about Morphic's eagerly awaited EMERALD-1 trial. Despite experiencing an initial surge in stock values following the release...

Ionis sees success in lipid reduction Phase 3 trial

Ionis Pharmaceuticals has achieved a significant milestone in their phase 3 clinical trial focused on therapies that reduce lipids. This achievement positions...

Overcoming Age-Related Challenges in Nanodrug Delivery for Pediatric Cancer Patients

The efficacy of medical treatments often varies with age, and this principle holds true in the world of nanodrug delivery for pediatric,...

60 Degrees Pharmaceuticals Halts Tafenoquine COVID-19 Trial in Response to FDA Recommendations

In accordance with FDA guidance, 60 Degrees Pharmaceuticals has opted to halt the Phase IIb trial for tafenoquine, known as ACLR8-LR. This...

Phase 3 trial data for Astellas’s GA drug yielded positive results

A mere six weeks after obtaining FDA approval, Astellas Pharma is already considering expanding the label for Izervay, an eye injection acquired...

UCB’s Psoriasis Drug Application Faces a Further FDA Delay

In May of this year, the FDA issued a full response letter that delayed the launch of UCB's bimekizumab treatment for psoriasis...

Promising BP-NELL-PEG compound may protect astronauts from rapid bone loss in space

After an unprecedented live return of mice from the International Space Station (ISS), the results were nothing short of astonishing. Soo, a...

CGM-connected app feature for Type 2 diabetes patients, unveiled by Abbott and WeightWatchers

One year after allying with the shared objective of enhancing health management for individuals diagnosed with Type 2 diabetes, Abbott and WeightWatchers...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm
- Advertisement -